Cargando…
SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma
SIMPLE SUMMARY: Glioblastoma is the most common malignant primary brain tumor and remains incurable. Additionally, there are only a few non-invasive early diagnostic and prognostic markers for this disease. The stability of extracellular vesicles (EVs) and their availability in patient serum make th...
Autores principales: | Ampudia-Mesias, Elisabet, El-Hadad, Samia, Cameron, Charles Scott, Wöhrer, Adelheid, Ströbel, Thomas, Saydam, Nurten, Saydam, Okay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028996/ https://www.ncbi.nlm.nih.gov/pubmed/35454889 http://dx.doi.org/10.3390/cancers14081984 |
Ejemplares similares
-
Extracellular-Vesicle-Based Cancer Panels Diagnose Glioblastomas with High Sensitivity and Specificity
por: Mut, Melike, et al.
Publicado: (2023) -
Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma
por: Ströbel, Thomas, et al.
Publicado: (2017) -
Deficiency of Ku Induces Host Cell Exploitation in Human Cancer Cells
por: Saydam, Okay, et al.
Publicado: (2021) -
Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation
por: Erkan, Erdogan Pekcan, et al.
Publicado: (2019) -
Antibody Profiling and In Silico Functional Analysis of Differentially Reactive Antibody Signatures of Glioblastomas and Meningiomas
por: Milchram, Lisa, et al.
Publicado: (2023)